Frontiers in Genetics (Oct 2022)

A pathogenic variant of TULP3 causes renal and hepatic fibrocystic disease

  • Hossein Jafari Khamirani,
  • Vivek Reddy Palicharla,
  • Seyed Alireza Dastgheib,
  • Mehdi Dianatpour,
  • Mehdi Dianatpour,
  • Mohammad Hadi Imanieh,
  • Seyed Sajjad Tabei,
  • Whitney Besse,
  • Saikat Mukhopadhyay,
  • Karel F. Liem

DOI
https://doi.org/10.3389/fgene.2022.1021037
Journal volume & issue
Vol. 13

Abstract

Read online

Patient variants in Tubby Like Protein-3 (TULP3) have recently been associated with progressive fibrocystic disease in tissues and organs. TULP3 is a ciliary trafficking protein that links membrane-associated proteins to the intraflagellar transport complex A. In mice, mutations in Tulp3 drive phenotypes consistent with ciliary dysfunction which include renal cystic disease, as part of a ciliopathic spectrum. Here we report two sisters from consanguineous parents with fibrocystic renal and hepatic disease harboring a homozygous missense mutation in TULP3 (NM_003324.5: c.1144C>T, p.Arg382Trp). The R382W patient mutation resides within the C-terminal Tubby domain, a conserved domain required for TULP3 to associate with phosphoinositides. We show that inner medullary collecting duct-3 cells expressing the TULP3 R382W patient variant have a severely reduced ability to localize the membrane-associated proteins ARL13b, INPP5E, and GPR161 to the cilium, consistent with a loss of TULP3 function. These studies establish Arginine 382 as a critical residue in the Tubby domain, which is essential for TULP3-mediated protein trafficking within the cilium, and expand the phenotypic spectrum known to result from recessive deleterious mutations in TULP3.

Keywords